Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Capture of biologic and biosimilar dispensings in a consortium of U.S.-based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims.
Zhang J, Haynes K, Mendelsohn AB, Marshall J, Barr CE, McDermott C, Brown J, Kline A, Kenney J, King KJ, Holmes C, Yeung K, Barron J, Yun H, Lockhart CM. Zhang J, et al. Among authors: barr ce. Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):778-785. doi: 10.1002/pds.4934. Epub 2019 Dec 4. Pharmacoepidemiol Drug Saf. 2020. PMID: 31802568
Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars.
Desai RJ, Kim SC, Curtis JR, Bosco JLF, Eichelberger B, Barr CE, Lockhart CM, Bradbury BD, Clewell J, Cohen HP, Gagne JJ; Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) Switching Workgroup. Desai RJ, et al. Among authors: barr ce. Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):757-769. doi: 10.1002/pds.4809. Epub 2019 Jul 12. Pharmacoepidemiol Drug Saf. 2020. PMID: 31298463 Review.
Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance.
Zhang J, Sridhar G, Barr CE, Eichelberger B, Lockhart CM, Marshall J, Clewell J, Accortt NA, Curtis JR, Holmes C, McMahill-Walraven CN, Brown JS, Haynes K. Zhang J, et al. Among authors: barr ce. J Manag Care Spec Pharm. 2020 Apr;26(4):417-490. doi: 10.18553/jmcp.2020.26.4.417. J Manag Care Spec Pharm. 2020. PMID: 32223608 Free PMC article.
Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group.
Faulkner E, Holtorf AP, Walton S, Liu CY, Lin H, Biltaj E, Brixner D, Barr C, Oberg J, Shandhu G, Siebert U, Snyder SR, Tiwana S, Watkins J, IJzerman MJ, Payne K. Faulkner E, et al. Value Health. 2020 May;23(5):529-539. doi: 10.1016/j.jval.2019.11.010. Epub 2020 Apr 1. Value Health. 2020. PMID: 32389217 Free article.
110 results